kt-413,kt-333
kymera therapeutics
['kt-333 ', 'solid tumor', 'kt-413', 'kymera therapeutics', 'kymeratx']
tune into #asco22 for trial updates on our leading #oncology candidates, kt-333 &amp; kt-413! learn more about how s degraders have the potential to transform the treatment of a broad range of liquid &amp; solid tumors. #clinicaltrials 
Advancing the field of targeted protein degradation to deliver breakthrough medicines for previously untreatable diseases